Delivery Order SPE2DB22D1106-SPE2DB25FFHB3
- Not listed
- The Defense Logistics Agency awarded a $3,720.51 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for Briviact 10 mg/ml oral solution (300 ml), with an ultimate completion date of July 15, 2025. This is a firm fixed-price, non-set-aside contract executed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,786.07 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count) on June 11, 2025, with an ultimate completion date of June 12, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $9,544.90 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor based on capability and pricing. The performance location is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $4,059.87 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. The contract is classified as a firm fixed price delivery order with an ultimate completion date of May 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $2,116.72. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Briviact 10 mg/ml oral solution in a 300 ml quantity, with a ceiling value of $1,861.78. This is a firm fixed-price delivery order with no set-aside designation, executed on a competitive basis. The contract is set to reach ultimate completion by June 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Briviact 10 mg/ml oral solution (300 ml) with a ceiling value of $3,723.56. The contract was competitively awarded without a set-aside designation under a firm fixed-price delivery order structure, with an ultimate completion date of September 22, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Briviact 10 mg/ml oral solution in a 300 ml quantity. This non-competitive delivery order carries a ceiling value of $5,097.53 and represents a firm fixed price contract with an ultimate completion date of September 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHB3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,682.58 to AmerisourceBergen Drug Corp for Briviact 10 mg/ml oral solution (300ml) on September 5, 2025, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen maintains an extensive portfolio of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. This delivery order exemplifies AmerisourceBergen's role as a prime pharmaceutical vendor within the DLA supply chain, fulfilling medical procurement needs for Defense Health Agency and other federal healthcare systems. The company's federal contract awards demonstrate consistent capability to deliver specialized pharmaceuticals across multiple therapeutic domains through competitive procurement processes. Under its comprehensive IDC vehicle, AmerisourceBergen supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities on a global scale to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 9/5/25 |